{"DataElement":{"publicId":"7263249","version":"1","preferredName":"Study Protocol Cohort Assignment Category","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._A group of individuals, identified by a common characteristic._An allotting or an appointment to a particular person or use, or for a particular time or object._A grouping of items based on some commonality or by user defined characteristics.","longName":"7263209v1.0:7263204v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"7263209","version":"1","preferredName":"Study Protocol Cohort Assignment","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._A group of individuals, identified by a common characteristic._An allotting or an appointment to a particular person or use, or for a particular time or object.","longName":"7263207v1.0:2454524v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"7263207","version":"1","preferredName":"Study Protocol Cohort","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.:A group of individuals, identified by a common characteristic.","longName":"C70817:C61512","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Protocol","conceptCode":"C70817","definition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4470DC8-24C9-47AF-E053-F662850A397A","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"ONEDATA","dateModified":"2020-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2454524","version":"1","preferredName":"Assignment","preferredDefinition":"Assignment; an undertaking that you have been assigned to do.","longName":"C25426","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assignment","conceptCode":"C25426","definition":"An allotting or an appointment to a particular person or use, or for a particular time or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E070B71-91E5-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-10","modifiedBy":"ONEDATA","dateModified":"2006-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4470DC8-24D7-47AF-E053-F662850A397A","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA5191, 04/27/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7263204","version":"1","preferredName":"Cohort Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"7263204v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Randomized cohort: Patients without molecular alterations","valueDescription":"Randomization Cohort Patient Without Eligible Molecular Abnormality","ValueMeaning":{"publicId":"7263205","version":"1","preferredName":"Randomization Cohort Patient Without Eligible Molecular Abnormality","longName":"7263205","preferredDefinition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.: A group of individuals, identified by a common characteristic.: A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Used to indicate the absence or lack of something or someone.: Satisfying the appropriate conditions for inclusion.: A molecular or cytogenic abnormality which occurs in either human disease states or disease models.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Randomization","conceptCode":"C25196","definition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A446FB38-EF70-559B-E053-F662850A6781","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"ONEDATA","dateModified":"2020-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A446FB38-EF8B-559B-E053-F662850A6781","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"ONEDATA","dateModified":"2020-04-27","deletedIndicator":"No"},{"value":"Targeted cohort: Patients with eligible molecular alterations","valueDescription":"Target Cohort Patient With Eligible Molecular Abnormality","ValueMeaning":{"publicId":"7263206","version":"1","preferredName":"Target Cohort Patient With Eligible Molecular Abnormality","longName":"7263206","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination.: A group of individuals, identified by a common characteristic.: A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Used to indicate the presence of something or someone.: Satisfying the appropriate conditions for inclusion.: A molecular or cytogenic abnormality which occurs in either human disease states or disease models.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A446FB38-EF9C-559B-E053-F662850A6781","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"ONEDATA","dateModified":"2020-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A446FB38-EFB7-559B-E053-F662850A6781","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"ONEDATA","dateModified":"2020-04-27","deletedIndicator":"No"},{"value":"1","valueDescription":"One","ValueMeaning":{"publicId":"2572563","version":"1","preferredName":"One","longName":"2572563","preferredDefinition":"The smallest natural number and quantity it denotes: a single entity, unit, or object. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E880-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-29","modifiedBy":"FINCHAMB","dateModified":"2022-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3E4-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"2","valueDescription":"Two","ValueMeaning":{"publicId":"5612444","version":"1","preferredName":"Two","longName":"5612444","preferredDefinition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45366610-073B-3B1B-E053-F662850AF490","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3F0-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"Cisplatin eligible","valueDescription":"Cisplatin Eligible","ValueMeaning":{"publicId":"7576034","version":"1","preferredName":"Cisplatin Eligible","longName":"7576034","preferredDefinition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.: Satisfying the appropriate conditions for inclusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cisplatin","conceptCode":"C376","definition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA987D1D-9401-7F6C-E053-4EBD850ACC97","latestVersionIndicator":"Yes","beginDate":"2021-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-05","modifiedBy":"ONEDATA","dateModified":"2021-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA995C09-BBEE-1430-E053-4EBD850A7DCE","beginDate":"2021-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-05","modifiedBy":"ONEDATA","dateModified":"2021-02-05","deletedIndicator":"No"},{"value":"Cisplatin ineligible","valueDescription":"Cisplatin Ineligibility","ValueMeaning":{"publicId":"6712212","version":"1","preferredName":"Cisplatin Ineligibility","longName":"6712212","preferredDefinition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.: The state or quality of being disqualified by law, rule, or provision.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cisplatin","conceptCode":"C376","definition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87362511-B262-24FC-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"ONEDATA","dateModified":"2019-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA995C09-BBF8-1430-E053-4EBD850A7DCE","beginDate":"2021-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-05","modifiedBy":"ONEDATA","dateModified":"2021-02-05","deletedIndicator":"No"},{"value":"No prior targeted therapy","valueDescription":null,"ValueMeaning":{"publicId":"13571184","version":"1","preferredName":"No prior targeted therapy","longName":"13571184v1.00","preferredDefinition":"The non-affirmative response to a question._Earlier in time or order._A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBEDD3E-C0A8-12A5-E053-731AD00A05AF","latestVersionIndicator":"Yes","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"SOKKERL","dateModified":"2023-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBEDD3E-C0AA-12A5-E053-731AD00A05AF","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"SOKKERL","dateModified":"2023-06-20","deletedIndicator":"No"},{"value":"Prior targeted therapy","valueDescription":null,"ValueMeaning":{"publicId":"13571185","version":"1","preferredName":"Prior Targeted Therapy","longName":"13571185v1.00","preferredDefinition":"Earlier in time or order._A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBEDD3E-C0A9-12A5-E053-731AD00A05AF","latestVersionIndicator":"Yes","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBEDD3E-C0AB-12A5-E053-731AD00A05AF","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A446FB38-EF54-559B-E053-F662850A6781","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"SOKKERL","dateModified":"2023-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Cohort","type":"Preferred Question Text","description":"Cohort","url":null,"context":"ECOG-ACRIN"},{"name":"OPEN Checklist","type":"Alternate Question Text","description":"Select the cohort status","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A447CF15-9FB4-41E0-E053-F662850A6D72","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"GARRIDOJ","dateModified":"2021-02-05","changeDescription":"Created for EA5191, 04/27/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}